Atlas Trials

Active Nonsegmental Vitiligo

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Active Nonsegmental Vitiligo

RecordFirmDate
A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2 (NCT06072183)Pfizer2023-11-08
A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo (NCT05583526)Pfizer2022-12-01

Track Active Nonsegmental Vitiligo automatically

Every clearance here is in the API, with alerts when new ones post.